Investigators have identified two promising new treatment options for men with recurrent prostate cancer -- both of which helped patients live longer without their disease progressing than the current ...

About 1 in 8 men will be diagnosed with prostate cancer in their lifetime The average age at diagnosis is 67 Less than 1% of the 3.5 million men living with prostate cancer are expected to die from it ...

A minimally-invasive treatment using MRI and transurethral ultrasound instead of surgery or radiation is effective in treating prostate cancer, according to new research to be presented at the Society ...

Learn what you need to know about early-stage prostate cancer, from risk factors to treatment options and how to tackle their side effects. Prostate cancer: 1 in 8 men in the United States will be ...

Have you or a loved one been diagnosed with prostate cancer? Understanding the various treatment options available for different stages of this disease can empower you to make informed decisions.

An expert explains the significance of the recent approval of Xtandi for non-metastatic castration-sensitive prostate cancer (nmCSPC) with biochemical recurrence at high risk for metastasis (high-risk ...

Reviewed by Peter E. Lonergan, MD, FRCS (Urol.), consultant urologist and clinical senior lecturer at St. James’s Hospital & Trinity College in Dublin, Ireland. Once you have been diagnosed with ...

Erleada showed a 23% reduction in mortality compared to Xtandi in real-world settings, offering potential survival benefits for metastatic castration-sensitive prostate cancer patients. Real-world ...

Patients say the difference it makes is amazing. A state-of-the-art laser prostate reduction operation is now being successfully delivered in the county as a day case procedure. HOLEP, or Holmium ...